latest news releases from the newsroom
Ceragenix and MAST BioSurgery Enter Into Joint Development Agreement for New Antimicrobial Surgical Products
DENVER, Apr 29, 2009 -- Ceragenix Pharmaceuticals, Inc. ("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that it has entered into a Joint Development Agreement ("JDA") with MAST BioSurgery Inc. ("MAST") for the development of one or more new surgical products incorporating Ceragenix's CeraShield(TM) antimicrobial technology. Under the terms of the JDA, MAST will have exclusive rights to develop specified products and negotiate commercialization terms for such products for a period of six months. This is the first joint development and exclusive option to license entered into by Ceragenix for a medical device application of its CeraShield(TM) antimicrobial technology.
Pak/Teem's Growth Requires Relocation to 2.5X Larger Facility
CINCINNATI, April 29, 2009 (GLOBE NEWSWIRE) -- At a time when some companies are downsizing, Pak/Teem is doing more than thinking BIG! The company is pleased to announce that it has moved to a much larger facility in Woodlawn, OH -- more than two and a half times the size of the previous building! The new location will better accommodate the company's continued growth in the areas of engineering, design, fabrication and manufacturing. Celebrating its 20th anniversary, Pak/Teem has built its business and reputation on the expertise of its personnel, the quality of its services and the long-term relationships the company has with its customers.
Universal Stainless & Alloy Products
Universal Stainless Reports First Quarter 2009 Results
BRIDGEVILLE, Pa., April 29, 2009 (GLOBE NEWSWIRE) -- Universal Stainless & Alloy Products, Inc. (Nasdaq:USAP) reported today that sales for the first quarter of 2009 were $42.2 million, which was at the high end of its forecast of $32 million to $42 million. This compares with sales of $56.8 million in the first quarter of 2008.